Ontology highlight
ABSTRACT:
SUBMITTER: Yuan T
PROVIDER: S-EPMC5439710 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
Yuan Ting T Zhang Feng F Yao Qing-Min QM Liu Yan-Xia YX Zhu Xiao-Juan XJ Wang Xin X
PloS one 20170522 5
<h4>Background</h4>Bortezomib is recently studied as a novel agent in indolent lymphoma. The optimal schedule of bortezomib used in indolent lymphoma is still uncertain.<h4>Methods</h4>We did a systematic review and meta-analysis of the clinical trials comparing the efficacy and toxicity of the weekly and biweekly schedules of bortezomib in patients with indolent lymphoma. We searched Pubmed, Cochrane Library and Emabase from inception to July 29, 2016. The primary outcome was the overall respon ...[more]